Park J P, Curran M J, Levy N B, Davis T H, Elliott J H, Mohandas T K
Department of Pathology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire 03756, USA.
Cancer Genet Cytogenet. 1997 Jul 15;96(2):118-22. doi: 10.1016/s0165-4608(96)00281-6.
We observed a translocation (2;22)(p23;q11.2) in the bone marrow cells of a patient with multiple subcutaneous nodules. Tumor histology and immunohistochemical staining demonstrated a malignant lymphoma, diffuse large cell type, displaying a CD30 negative B cell immunophenotype. To our knowledge, this is the first report of this specific translocation in lymphoma, which may join the site of the anaplastic lymphoma kinase (ALK) gene at 2p23 to the region of the immunoglobulin lambda light chain gene at 22q11.2. The ALK gene was initially identified through its involvement in the t(2;5)(p23;q35) found most commonly in anaplastic large cell lymphoma. This observation in a CD30 negative large cell lymphoma of B cell lineage further extends the relationship of anaplastic large cell morphology, ALK activation, lymphoid lineage, and expression of the CD30 antigen.
我们在一名患有多个皮下结节的患者的骨髓细胞中观察到一种(2;22)(p23;q11.2)易位。肿瘤组织学和免疫组化染色显示为弥漫大B细胞型恶性淋巴瘤,表现为CD30阴性B细胞免疫表型。据我们所知,这是淋巴瘤中这种特定易位的首次报道,它可能将位于2p23的间变性淋巴瘤激酶(ALK)基因位点与位于22q11.2的免疫球蛋白λ轻链基因区域连接起来。ALK基因最初是通过其参与在间变性大细胞淋巴瘤中最常见的t(2;5)(p23;q35)而被鉴定出来的。在B细胞系CD30阴性大细胞淋巴瘤中的这一观察结果进一步扩展了间变性大细胞形态、ALK激活、淋巴系以及CD30抗原表达之间的关系。